News

Dodd-Frank Implementation Faces Strong Congressional Opposition

Dodd-Frank Implementation Faces Strong Congressional Opposition

Members of Congress introduce legislation to roll back Dodd-Frank and limit funds appropriated to financial regulatory agencies.

FDA Seeks Public Input and Increased Funding to Implement Food Safety Act

FDA Seeks Public Input and Increased Funding to Implement Food Safety Act

The FDA holds public meetings to discuss its new authority as some members of Congress question the agency’s budget.

Week in Review

Week in Review

Regulatory news in review

Federal Reserve Rule Restricts Mortgage Brokers’ Compensation

Federal Reserve Rule Restricts Mortgage Brokers’ Compensation

Federal Reserve issues a new rule to protect consumers from unfair mortgage practices.

Consumer Financial Protection Bureau Updates Website

Consumer Financial Protection Bureau Updates Website

New consumer protection agency prepares to assume its responsibilities in July.

Week in Review

Week in Review

Regulatory news in review

Sunshine Week Brings New FOIA.gov, But Critics Say Glass is Still Half Full

Sunshine Week Brings New FOIA.gov, But Critics Say Glass is Still Half Full

New government website teaches users how to request government information but with mixed reactions.

The House May Block Funding to Implement the FCC’s Net Neutrality Rules

The House May Block Funding to Implement the FCC’s Net Neutrality Rules

The FCC’s newly adopted rules aim to ensure freedom and openness, but face appropriations hurdles.

Week in Review

Week in Review

Regulatory news in review

USDA Fully Deregulates Genetically Modified Alfalfa

USDA Fully Deregulates Genetically Modified Alfalfa

Following Supreme Court decision, the USDA stops regulating Roundup Ready Alfalfa.

Democrats and Republicans Wrangle Over the FCC’s Net Neutrality Rules

Democrats and Republicans Wrangle Over the FCC’s Net Neutrality Rules

Congress debates whether net neutrality rules promote competition and innovation or stifle economic activity.

Ongoing Litigation in Human Embryonic Stem Cell Research

Ongoing Litigation in Human Embryonic Stem Cell Research

Lawsuits over stem cell research could alter current scientific approaches.